Frank Stonebanks

Southlake Biotech Renibus Therapeutics Garners $33M in Bridge Financing

by | Dec 8, 2022
Southlake-based Renibus Therapeutics—a clinical-stage biotech company developing innovative products for cardiorenal diseases—has received $33 million in bridge financing to help it advance three drugs in its pipeline. The drugs are currently in various phases of trials.
MORE
DI People: Addverb, Renibus Therapeutics, Denton EDP, Fort Worth Executive Roundtable, RumbleOn, and More Make Moves
In this week's roundup of hires, promotions, and accolades in North Texas, you'll also find news from VERTESS, Mr. Cooper, Active Cyber, EarthX, SWK Holdings, and more.

Plus, Fort Worth Mayor Mattie Parker makes an appointment to the city council's Entrepreneurship and Innovation Committee.
MORE
With New Funding and CEO, This Southlake Biotech is Looking to Solve Kidney Disease
by | Feb 16, 2022
Renibus Therapeutics, which focuses on treatments for acute and chronic kidney diseases, announced closing a $35 million Series A funding round. Its new CEO, Frank Stonebanks, says "Renibus has arrived at a critical inflection point in its commitment to transform the prevention and treatment of kidney diseases."
MORE